An integrative approach to inform optimal administration of OX40 agonist antibodies in patients with advanced solid tumors

  1. Wang, R.
  2. Gao, C.
  3. Raymond, M.
  4. Dito, G.
  5. Kabbabe, D.
  6. Shao, X.
  7. Hilt, E.
  8. Sun, Y.
  9. Pak, I.
  10. Gutierrez, M.
  11. Melero, I.
  12. Spreafico, A.
  13. Carvajal, R.D.
  14. Ong, M.
  15. Olszanski, A.J.
  16. Milburn, C.
  17. Thudium, K.
  18. Yang, Z.
  19. Feng, Y.
  20. Fracasso, P.M.
  21. Korman, A.J.
  22. Aanur, P.
  23. Huang, S.-M.A.
  24. Quigley, M.
Aldizkaria:
Clinical Cancer Research

ISSN: 1557-3265 1078-0432

Argitalpen urtea: 2019

Alea: 25

Zenbakia: 22

Orrialdeak: 6709-6720

Mota: Artikulua

DOI: 10.1158/1078-0432.CCR-19-0526 GOOGLE SCHOLAR

Garapen Iraunkorreko Helburuak